In a cross-sectional clinical study published in Respiratory Medicine, Odil Garrido Campos de Andrade and colleagues compared 35 patients with PAH with 40 age- and sex-matched controls to evaluate the prevalence of metabolic disorders. Patients with PAH showed higher A1C levels (6.1% vs 5.57%; P=0.006), a greater prevalence of hypothyroidism (22.9% vs 2.5%; P=0.007), and hyperparathyroidism (23% vs 0%). Bone mineral density (BMD) was significantly lower in the PAH group, with total hip and femoral neck Z-scores of −0.15 ±1.25 and −0.14 ±1.07 compared with controls (0.50 ±1.13 and 0.35 ±0.94; P=0.021 and P=0.038, respectively). Patients with PAH also had a higher prevalence of osteopenia or osteoporosis (34% vs 20%; RR, 2.13). The researchers emphasized the need for targeted management strategies and further research to elucidate mechanisms underlying the heightened prevalence of metabolic disorders in PAH.
The post Metabolic Disorders Higher in PAH vs Controls first appeared on Physician's Weekly.